Creative Biolabs Blog

Menu

Skip to content
  • Drug Discovery Research
  • Immunotherapy Research
  • Antibody Engineering Research

Industry Leader

With extensive experience, Creative Biolabs aims to offer you the best in the field of antibody

De Novo Antibody Sequencing

Antibody Sequencing Service Supports Your Antibody Engineering with All-around Service System.

Global Market

Creative Biolabs serves customers from the USA, Canada, European countries and more

Single Domain Antibody

Single domain antibody—the most promising antibody in disease diagnosis, genetic modification and more

11Apr/21

CD47-related Signaling Pathways & Research Progress on the Relationship with Related Diseases (Part Two)

April 11, 2021Biological KnowledgeCD47, CD47 Signaling Pathwaysbiolabs

2 CD47-related Signaling Pathways The extracellular ligands interacting with CD47 are TSP1, SIRP α, and CD47 itself. Among them, little is known about the signal transduction involved in the homotypic interaction ofRead More…

11Apr/21

CD47-related Signaling Pathways & Research Progress on the Relationship with Related Diseases (Part One)

April 11, 2021Biological KnowledgeCD47, Protein, Protein Protein Interactionbiolabs

Cluster of differentiation 47 (CD47) is a widely expressed glycoprotein on the cell surface, which can interact with a variety of intracellular and extracellular proteins such as thrombospondin-1 (TSP-1) and signal regulatoryRead More…

09Mar/21

Sci Rep: Monoclonal Antibody can Effectively Treat Malaria

March 9, 2021Newsimmunotherapy, monoclonal antibody, Therapeutic Antibodybiolabs

Recently, scientists at the Walter Reed Army Institute have confirmed that monoclonal antibodies can be an effective tool in the global fight against malaria. The study, led by Dr. Sheetij Dutta, theRead More…

06Feb/21

Multivalent Single Domain Antibodies Help Block SARS-CoV-2 Infection and Suppress Mutational Escape

February 6, 2021Antibody Engineering Research, Immunotherapy ResearchAntibody Discovery, COVID-19, single domain antibodybiolabs

In a new study, an international team led by the University of Bonn identified and further developed the novel single-domain antibodies (sdAbs) against SARS-CoV-2. The researchers also combined these single-domain antibodies intoRead More…

08Jan/21

Nat Methods: How to Enhance the Effect of T Cell Therapy?

January 8, 2021Immunotherapy Researchimmunotherapy, T cell receptorbiolabs

In a recent study, the scientists at UT Southwestern have developed a new method to study the molecular characteristics of T cells. The method, published on Nature Methods, makes it easier forRead More…

10Dec/20

New TCR Therapy—Tebentafusp

December 10, 2020Immunotherapy Research, Newstcr, Therapeutic Antibodybiolabs

Recently, the phase 3 clinical trial results of T cell receptor (TCR) therapy, tebentafusp, have been released. The results showed that it reached the primary endpoint in the treatment of metastatic uvealRead More…

03Nov/20

eLife: The New Anticancer Mechanism of T Cells

November 3, 2020Immunotherapy ResearchCAR-T, immunotherapybiolabs

A new study published on eLife shows when T cells in the immune system find and identify targets, they release chemicals to attract more T cells, and then gather to help suppressRead More…

12Oct/20

The Discoverers of Hepatitis C Virus Won the 2020 Nobel Prize in Physiology or Medicine

October 12, 2020NewsHepatitis C Virus, nobel prize, virusbiolabs

The 2020 Nobel Prize in Physiology or Medicine is awarded jointly to Harvey J. Alter, Michael Houghton and Charles M. Rice “for the discovery of Hepatitis C virus”. Thanks to their discovery,Read More…

02Sep/20

COVID-19 May Lead to the Loss of Important Immune Structure—It Is Expected to Explain the Cause of Secondary Infection in Recovered Patients

September 2, 2020Biological Knowledge, NewsCOVID-19, Immune Response, virusbiolabs

According to the latest report from the Science, four research institutions, including Massachusetts Institute of Technology and Harvard University, conducted an autopsy analysis on patients who died of COVID-19 and found thatRead More…

23Aug/20

What Are the Development Prospects & Anticancer Potential of CD38 Antibodies?

August 23, 2020Drug Discovery Research, Immunotherapy Researchimmunotherapy, monoclonal antibody, Therapeutic Antibodybiolabs

CD38 protein, which was discovered in 1980, is a type II transmembrane glycoprotein with a size of 46 kDa. The ligand of CD38 is CD31, also known as PECAM-1, which is aRead More…

Posts navigation

  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 17
  • Next »

Categories

  • Antibody Engineering Research
  • Biological Knowledge
  • Drug Discovery Research
  • Immunotherapy Research
  • News

Recent Posts

  • Scientists identify a special gene that produces key antibodies in large quantities
  • The molecular mechanism by which special antibodies protect the body against HIV infection
  • Multispecific antibodies enhance cancer immunotherapy
  • Scientists have cracked HIV’s new way of entering the host cell nucleus, which may lead to new therapeutic drugs
  • Antibody sequencing provides a new path for antibody therapy research

Archives

Contact Us

USA – UK

Copyright © Creative Biolabs Blog
Powered by WordPress , Theme i-max by TemplatesNext.
MENU
  • Drug Discovery Research
  • Immunotherapy Research
  • Antibody Engineering Research